hakan_bjorklund

Lundbeck elects new chairman

pharmafile | February 21, 2013 | Appointment | Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Lundbeck 

Lundbeck has announced it will be electing Håkan Björklund as its new chairman as Mats Pettersson steps down.

Pettersson, a member of Lundbeck’s Board of directors since 2003, and chairman since 2011, has announced that he will not be seeking re-election.

Björklund (pictured) said: “I have in-depth knowledge of Lundbeck after two years as a board member, and I look forward to contributing to Lundbeck’s progress and future growth in my role as chairman.”

Advertisement

Pettersson added: “I have held a seat on the Board of directors of Lundbeck for nearly ten years, acting as chairman for close to two years. I have had ten very exciting years, and it has been a privilege to contribute to developing Lundbeck and expanding the company’s strong position.”

He continued: “Lundbeck is well prepared to face the future, building on its strong platform for long-term growth, and I have decided that this was the right time to pass the baton to a new board member and chairman”.

New board candidate
Lundbeck’s Board of directors will also nominate Lars Rasmussen, chief executive of Coloplast A/S, as new board member at the next annual general meeting. 

The Board will also propose re-election of Christian Dyvig, Thorleif Krarup, Jes Østergaard and Melanie Lee, and expects to re-elect Christian Dyvig as deputy chairman of the Board of directors.

Related Content

Otsuka and Lundbeck gain FDA approval for supplemental New Drug Application for dementia drug

Japan-based healthcare company Otsuka Pharmaceutical and Danish pharma company Lundbeck have announced that the US …

Lundbeck to restructure R&D, shedding up to 160 jobs

Danish neuroscience specialist Lundbeck has announced it will be implementing a restructure of its Research …

Lundbeck’s Vyepti secures US approval for migraine prevention

Lundbeck’s Vyepti (eptinezumab-jjmr) has secured approval from the FDA, it has emerged, for the prevention …

The Gateway to Local Adoption Series

Latest content